Evaluation of third wave Invader® HPV detection assay and comparison with Digene Hybrid Capture II results

被引:0
|
作者
Quigley, D. I. [1 ]
Brown, C. B. [1 ]
Foxworth, C. F. [1 ]
Re, G. G. [1 ]
Hoda, R. [1 ]
Wolff, D. J. [1 ]
机构
[1] Med Univ S Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA
来源
JOURNAL OF MOLECULAR DIAGNOSTICS | 2006年 / 8卷 / 05期
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
引用
收藏
页码:656 / 656
页数:1
相关论文
共 50 条
  • [21] HPV Genotyping of ThinPrep (Cytec) Cervical Cytology Samples with Weakly Positive Hybrid Capture 2 (Digene) Results
    Cleaves, C.
    Hocker, K.
    Sayage-Rabie, L.
    Watson, L.
    Taylor, M.
    Nagori, S.
    Pearson, V.
    Rao, A.
    LABORATORY INVESTIGATION, 2009, 89 : 83A - 83A
  • [22] HPV Genotyping of ThinPrep (Cytec) Cervical Cytology Samples with Weakly Positive Hybrid Capture 2 (Digene) Results
    Cleaves, C.
    Hocker, K.
    Sayage-Rabie, L.
    Watson, L.
    Taylor, M.
    Nagori, S.
    Pearson, V.
    Rao, A.
    MODERN PATHOLOGY, 2009, 22 : 83A - 83A
  • [23] Comparison of the Bayer VERSANT HCV genotyping assay (LiPA) and the third wave invader HCV genotyping assay
    Barth, D
    Zhang, F
    Elagin, S
    Law, S
    Ginocchio, CC
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2004, 6 (04): : 425 - 426
  • [24] Comparison of the Roche cobas® 4800 and Digene Hybrid Capture® 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial
    Darrel A. Cook
    Wendy Mei
    Laurie W. Smith
    Dirk J. van Niekerk
    Kathy Ceballos
    Eduardo L. Franco
    Andrew J. Coldman
    Gina S. Ogilvie
    Mel Krajden
    BMC Cancer, 15
  • [25] Comparison of the Roche cobas® 4800 and Digene Hybrid Capture® 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial
    Cook, Darrel A.
    Mei, Wendy
    Smith, Laurie W.
    van Niekerk, Dirk J.
    Ceballos, Kathy
    Franco, Eduardo L.
    Coldman, Andrew J.
    Ogilvie, Gina S.
    Krajden, Mel
    BMC CANCER, 2015, 15
  • [26] Comparison of DR. HPV™ Chip Kit with hybrid capture II assay for the detection of human papillomavirus in clinical samples:: a preliminary study
    Saini, Rajan
    Shen, Tae H.
    Santhanam, Jacinta
    Othman, Nor Hayati
    Othman, Norodiyah
    Hock, Tang Thean
    TROPICAL BIOMEDICINE, 2007, 24 (01) : 17 - 22
  • [27] Multicenter comparison of the digene Hybrid Capture CMV DNA assay (version 2.0), the pp65 antigenemia assay, and cell culture for detection of cytomegalovirus viremia
    Mazzulli, T
    Drew, LW
    Yen-Lieberman, B
    Jekic-McMullen, D
    Kohn, DJ
    Isada, C
    Moussa, G
    Chua, R
    Walmsley, S
    JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (04) : 958 - 963
  • [28] Comparison of the digene hybrid capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal pap smear results
    Stevens, Matthew P.
    Garland, Suzanne M.
    Rudland, Elice
    Tan, Jeffrey
    Quinn, Michael A.
    Tabrizi, Sepehr N.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (07) : 2130 - 2137
  • [29] Use of Cervista HPV HR assay for detection of human papillomavirus in samples with hybrid capture borderline negative results
    Galan-Sanchez, Fatima
    Rodriguez-Iglesias, Manuel A.
    APMIS, 2010, 118 (09) : 681 - 684
  • [30] Development of a quantitative real time detection assay for Hepatitis B virus DNA and comparison with Digene Hybrid Capture and roche amplicor assays.
    Nimesters, HGM
    Pas, SD
    Fries, E
    de Man, RA
    Osterhaus, AD
    HEPATOLOGY, 2000, 32 (04) : 576A - 576A